COVID-19
Pseudomonas aeruginosa
antimicrobial stewardship
bloodstream infections
broad-spectrum antibiotic treatments
multi-drug resistant bacteria (MDR)
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
14 Mar 2023
14 Mar 2023
Historique:
received:
30
01
2023
revised:
07
03
2023
accepted:
13
03
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
Bacterial co-infections increase the severity of respiratory viral infections and are frequent causes of mortality in COVID-19 infected subjects. During the COVID-19 period, especially at the beginning of the pandemic, an inappropriate use of broad-spectrum antibiotic treatments has been frequently described, mainly due to prolonged hospitalization, especially in intensive care unit departments, and the use of immune-suppressive treatments as steroids. This misuse has finally led to the occurrence of infections by multi-drug resistant (MDR) bacteria in hospitalized COVID-19 patients. Although different reports assessed the prevalence of Gram-negative infections in COVID-19 infected patients, scarce data are currently available on bloodstream infections caused by
Identifiants
pubmed: 36983256
pii: jcm12062252
doi: 10.3390/jcm12062252
pmc: PMC10056033
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Ann Intern Med. 2021 May;174(5):613-621
pubmed: 33460330
Eur J Clin Invest. 2021 Dec;51(12):e13687
pubmed: 34599600
Antibiotics (Basel). 2021 Aug 02;10(8):
pubmed: 34438985
J Glob Antimicrob Resist. 2020 Dec;23:398-400
pubmed: 33242674
J Intensive Care Soc. 2022 Nov;23(4):500-502
pubmed: 36751343
J Clin Med. 2021 Feb 03;10(4):
pubmed: 33546093
Expert Rev Clin Immunol. 2020 Feb;16(2):207-228
pubmed: 31852268
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):495-502
pubmed: 33389263
Epidemiol Infect. 2022 Nov 08;150:e195
pubmed: 36345840
J Hosp Infect. 2022 Aug;126:29-36
pubmed: 35472487
Eur J Clin Invest. 2020 Oct;50(10):e13319
pubmed: 32535894
Infect Control Hosp Epidemiol. 2022 Jun;43(6):815-817
pubmed: 33685542
Infect Control Hosp Epidemiol. 2022 Dec 01;:1-8
pubmed: 36451285
Ann Intensive Care. 2020 Sep 7;10(1):119
pubmed: 32894364
Am J Infect Control. 2022 Mar;50(3):245-249
pubmed: 34971717
Lancet. 2023 Dec 17;400(10369):2221-2248
pubmed: 36423648
Antibiotics (Basel). 2021 Jan 29;10(2):
pubmed: 33573070
Microorganisms. 2021 Aug 20;9(8):
pubmed: 34442852
J Hosp Infect. 2022 May;123:191-192
pubmed: 35245646
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Antimicrob Resist Infect Control. 2020 Sep 22;9(1):154
pubmed: 32962759
BMC Infect Dis. 2021 Sep 8;21(1):933
pubmed: 34496787
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Intensive Care. 2021 Jan 18;9(1):10
pubmed: 33461613
Microorganisms. 2021 Sep 23;9(10):
pubmed: 34683337
Chest. 2021 Aug;160(2):454-465
pubmed: 33857475
Infect Prev Pract. 2022 Dec;4(4):100241
pubmed: 36061570
J Clin Med. 2020 Aug 25;9(9):
pubmed: 32854334
Crit Care. 2022 Oct 18;26(1):319
pubmed: 36258239
Infect Control Hosp Epidemiol. 2022 Mar;43(3):291-297
pubmed: 33896442
New Microbiol. 2021 Jan;44(1):51-58
pubmed: 33755185
Euro Surveill. 2020 Nov;25(45):
pubmed: 33183403
J Clin Virol. 2020 Jun;127:104364
pubmed: 32311650
Engineering (Beijing). 2020 Oct;6(10):1178-1184
pubmed: 33520333
JAMA Netw Open. 2021 Mar 1;4(3):e210417
pubmed: 33666657
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
PLoS One. 2020 Nov 23;15(11):e0242533
pubmed: 33226995
Rev Med Virol. 2022 May;32(3):e2295
pubmed: 34558756
Infect Disord Drug Targets. 2022;22(5):77-84
pubmed: 35440319
J Hosp Infect. 2020 Sep;106(1):198-199
pubmed: 32425287
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684
pubmed: 32433765
J Hosp Infect. 2022 Feb;120:43-47
pubmed: 34808311
J Clin Med. 2021 Apr 17;10(8):
pubmed: 33920701
Antibiotics (Basel). 2022 Jun 20;11(6):
pubmed: 35740232
J Microbiol Immunol Infect. 2020 Aug;53(4):505-512
pubmed: 32482366
Crit Care. 2021 Nov 22;25(1):403
pubmed: 34809698
Open Forum Infect Dis. 2022 Apr 05;9(6):ofac083
pubmed: 35607701
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Int J Antimicrob Agents. 2020 Dec;56(6):106179
pubmed: 32987104
Int J Antimicrob Agents. 2021 Apr;57(4):106324
pubmed: 33746045
Crit Care Med. 2021 Jan 1;49(1):e31-e40
pubmed: 33122577
Infect Control Hosp Epidemiol. 2021 Sep;42(9):1156-1158
pubmed: 32843125
Lancet Microbe. 2021 Aug;2(8):e354-e365
pubmed: 34100002
Antimicrob Resist Infect Control. 2022 Mar 7;11(1):45
pubmed: 35255988
J Hosp Infect. 2021 Apr;110:165-171
pubmed: 33561503
J Infect Public Health. 2021 May;14(5):555-560
pubmed: 33848884
Clin Microbiol Infect. 2021 Jan;27(1):83-88
pubmed: 32745596
Antibiotics (Basel). 2022 Aug 03;11(8):
pubmed: 36009922
Antibiotics (Basel). 2022 Jul 09;11(7):
pubmed: 35884179
Curr Opin Crit Care. 2020 Oct;26(5):433-441
pubmed: 32739970
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468
pubmed: 32358954
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399
pubmed: 32603803
iScience. 2021 Apr 23;24(4):102304
pubmed: 33748695
J Hosp Infect. 2021 Nov;117:147-156
pubmed: 34562548
BMC Infect Dis. 2020 Sep 1;20(1):646
pubmed: 32873235
J Fungi (Basel). 2020 Jun 30;6(3):
pubmed: 32630111
Pathogens. 2020 Aug 05;9(8):
pubmed: 32764228
BMC Infect Dis. 2021 Sep 21;21(1):985
pubmed: 34548027
Open Forum Infect Dis. 2020 Nov 12;7(11):ofaa518
pubmed: 33269299
Clin Microbiol Rev. 2019 Oct 30;33(1):
pubmed: 31666280